Glenmark Pharma shares in focus after FDA grants fast track status to cancer drug
Glenmark Pharmaceuticals
shares will be in focus on Tuesday after the company announced that its innovation arm, Ichnos Glenmark Innovation (IGI), has received 'fast track' designation from the US Food and Drug Administration (FDA) for its investigational therapy ISB 2001.
The designation applies to adult patients with relapsed or refractory multiple myeloma (RRMM) who have received at least three prior lines of treatment, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 monoclonal antibody.
ISB 2001 is a tri-specific antibody therapeutic designed to target BCMA and CD38 on myeloma cells, as well as CD3 on T cells, enabling a targeted immune response against cancer. The therapy is currently being evaluated in a Phase 1 dose expansion clinical study.
Play Video
Pause
Skip Backward
Skip Forward
Unmute
Current Time
0:00
/
Duration
0:00
Loaded
:
0%
0:00
Stream Type
LIVE
Seek to live, currently behind live
LIVE
Remaining Time
-
0:00
1x
Playback Rate
Chapters
Chapters
Descriptions
descriptions off
, selected
Captions
captions settings
, opens captions settings dialog
captions off
, selected
Audio Track
default
, selected
Picture-in-Picture
Fullscreen
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
Text
Color
White
Black
Red
Green
Blue
Yellow
Magenta
Cyan
Opacity
Opaque
Semi-Transparent
Text Background
Color
Black
White
Red
Green
Blue
Yellow
Magenta
Cyan
Opacity
Opaque
Semi-Transparent
Transparent
Caption Area Background
Color
Black
White
Red
Green
Blue
Yellow
Magenta
Cyan
Opacity
Transparent
Semi-Transparent
Opaque
Font Size
50%
75%
100%
125%
150%
175%
200%
300%
400%
Text Edge Style
None
Raised
Depressed
Uniform
Drop shadow
Font Family
Proportional Sans-Serif
Monospace Sans-Serif
Proportional Serif
Monospace Serif
Casual
Script
Small Caps
Reset
restore all settings to the default values
Done
Close Modal Dialog
End of dialog window.
Ichnos Glenmark Innovation recently completed the dose escalation portion of its Phase 1 clinical trial in patients with heavily pre-treated multiple myeloma.
Initial results from the study, presented during an oral session at the American Society of Hematology (ASH) Annual Meeting in December 2024, demonstrated a high overall response rate (ORR), durable responses, and a favorable safety profile.
Live Events
Complete results from the dose escalation portion will be presented in a rapid oral session at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting on Monday, June 2, 2025.
The FDA's fast track designation is intended to facilitate the development and accelerate the review of drugs that treat serious conditions and address unmet medical needs, with the goal of making important new treatments available to patients sooner.
A drug granted fast track status may be eligible for more frequent meetings and communications with the FDA, as well as rolling review of any marketing application.
It may also qualify for priority review if certain criteria are met. Notably, ISB 2001 was previously granted 'orphan drug' designation by the FDA in July 2023.
Also Read:
8 Nifty Microcap stocks that can jump 100-230% in the next 12 months
Glenmark Pharma: Price Target
According to Trendlyne data, the average target price for the stock is Rs 1,691, indicating an upside of 20% from current levels. The consensus recommendation from 12 analysts is a 'Buy'.
Also Read:
5 timeless Warren Buffett quotes every investor should know
Glenmark Pharma: Share price performance
On Monday,
Glenmark Pharma shares
closed 2.2% higher at Rs 1,405.7 on the BSE, while the benchmark Sensex rose 0.37%. The stock has declined 13% year-to-date but has surged 155% over the past two years. Its current market capitalisation stands at Rs 39,670 crore.
Also Read:
SBI, LIC among 10 large-cap stocks that are below industry PE levels can rally up to 32%
(
Disclaimer
: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
an hour ago
- Hindustan Times
Eggs recall: Here's why 1.7 million brown eggs have been recalled. Check the 9-state distribution list
August Egg Company has announced a recall of 1.7 million brown cage-free and certified organic brown eggs due to potential salmonella contamination. The FDA warns that Salmonella can cause serious and sometimes fatal infections, especially in young children, the elderly, and those with weakened immune systems. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. include eggs, milk, fish, wheat, soybeans, crustacean shellfish, sesame, tree nuts, and peanuts. Also Read: From Santa Claus to Adolf Hitler: See full list of baby names banned in the US According to the alert issued by the FDA warned that some of these contaminated eggs were distributed to grocery stores including Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less, and Ralphs. These eggs were distributed between February 3, 2025, to May 15, 2025, and had the sell-by dates of March 4, 2025, and June 4, 2025, stamped on them in both California and Nevada. In addition, another set of eggs was distributed from February 3, 2025, to May 6, 2025, with sell-by dates of March 4, 2025, and June 19, 2025, in Walmart stores in nine states. Consumers are urged to check their egg cartons for plant code numbers P-6562 or CA5330, along with Julian Dates ranging from 032 to 126. These identifiers, printed on the packaging, help trace the affected products. Julian Dates are typically three to seven-digit codes that indicate the exact day the eggs were packed, according to the FDA. The alert said, 'This recall is associated with an ongoing outbreak investigation of Salmonella Enteritidis illnesses,' adding that the investigation is related to the products distributed in the nine states, as reported by Newsweek. Also Read: Summer Game Fest 2025: Resident Evil, Mafia, and more — Here are the 5 biggest trailer drops The following are the nine states where the salmonella-contaminated eggs were distributed. These include: Illinois Indiana Nebraska New Mexico California Washington Nevada Arizona Wyoming
The Hindu
an hour ago
- The Hindu
Doctors raise alarm over rise in brain tumour cases
On the eve of World Brain Tumour Day (June 8), doctors in Hyderabad have sounded an alarm over the rising cases of brain tumour, and urged the public to recognise early symptoms and seek diagnosis and treatment. With over 40,000 new cases reported in India each year, according to the Indian Council of Medical Research (ICMR), medical experts say that delayed detection affects the outcome. Brain tumours, which can be benign or malignant, often begin with symptoms such as persistent headaches, seizures, memory loss, limb weakness, or vision and speech disturbances. Despite the slow onset, the condition can escalate quickly, turning into a life-threatening emergency, say doctors. Power of 3' campaign Care Hospitals is reinforcing its commitment to neurological emergency response through its 'Power of 3' campaign, a pledge that ensures emergency calls are answered within three rings, ambulances are dispatched within 30 minutes, and patients receive immediate ER attention. 'In neurological cases like brain tumours, every minute counts. Our campaign is not just about awareness but delivering timely, and expert care,' said Dr. Arun Reddy, Senior Neurosurgeon. As part of its campaign, Care Hospitals is focusing on symptom literacy, highlighting on warning signs like imbalance, seizures, or sudden memory issues that must not be ignored. 20% increase Olive Hospital doctors say they have noticed a 20% increase in brain tumour consultations over the last one year. 'Brain tumours are deceptive. Symptoms may appear ordinary, like a nagging headache but they could be signs of something far more serious. Early detection improves both survival and quality of life,' said Dr. Mohammed Mahmood Ali, Senior Neurologist. Breakthroughs in treatment Parallelly, doctors are optimistic about the breakthroughs in brain tumour treatment. 'We are witnessing a revolution in brain tumour care. Advanced neuro-navigation, intraoperative imaging, stereotactic radiosurgery, and robotic-assisted interventions are now standard practices. Precision medicine, including targeted therapies and FDA-approved drugs like vorasidenib for low-grade gliomas, is also changing outcomes,' said Dr. V. Naveen Reddy, Consultant Neurosurgeon at Renova Hospitals. Emerging strategies like immunotherapy, Tumour Treating Fields (TTFields), and even experimental mRNA vaccines are offering new hope. At the same time, Artificial Intelligence is being explored to assist with early, non-invasive diagnosis and treatment planning, he added.
Time of India
2 hours ago
- Time of India
Study finds Ozempic is linked to severe eye bleeding disorder in patients; experts share risk factors
A shocking study conducted in Israel has found that patients who take Ozempic or similar weight-loss drugs face a potential blinding condition due to internal bleeding in the eyes. According to the Daily Mail, patients who take the weight-loss shots were twice as likely to suffer from a serious degenerative eye disease as compared to those who do not take them. The particular condition is called neovascular age-related macular degeneration (nAMD), which mostly causes leaky blood vessels to grow behind the eye. This can even spill fluid into the retina, leading to permanent damage and blindness in the future. But is Ozempic really linked to bleeding of the eyes? Ozempic (semaglutide) is a medication prescribed to treat type 2 diabetes and help with weight loss. "Although it has been proven to have remarkable effects in regulating blood sugar and facilitating weight loss, it also comes with various issues and possible side effects," says Dr. Bhumesh Tyagi, Senior Consultant, Internal Medicine, Sharda Hospital. On the other hand, "Nausea, vomiting, diarrhoea, and constipation are the usual side effects. Serious complications can include pancreatitis, kidney, and gallbladder problems," adds Dr. Tyagi. Others have reported the risk of thyroid tumours, but this has been seen largely in animal studies. While the exact link between weight-loss drugs and vision problems isn't known, scientists believe that they bind to GLP-1 receptors in the eye, triggering the growth of the blood vessels. However, the cases were rare, but experts warned of the concerning signal in the data, saying that further research is needed to confirm the condition. FDA approved Ozempic to lower kidney disease in type 2 diabetics On the other hand, a few months ago, the FDA approved Ozempic to lower kidney disease in type 2 diabetes patients. "Chronic kidney disease (CKD) affects between 30 to 40 per cent of individuals living with type 2 diabetes in India, making it one of the most common and serious complications associated with the condition," says Dr. Rajiv Kovil, Head of Diabetology, Zandra Healthcare & Co-founder, Rang De Neela Initiative. Across the globe, including in India, diabetes-related complications are heavily linked to both cardiovascular and kidney disorders.
